Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients

G protein-coupled oestrogen receptor 1 (GPER), also called G protein-coupled receptor 30 (GPR30), is attracting considerable attention for its potential role in breast cancer development and progression. Activation by oestrogen (17β-oestradiol; E2) initiates short term, non-genomic, signalling event...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Stewart G., Lebot, Marie N., Sukkarn, Bhudsaban, Ball, Graham, Green, Andrew R., Rakha, Emad A., Ellis, Ian O., Storr, Sarah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995224/
https://www.ncbi.nlm.nih.gov/pubmed/29899833
http://dx.doi.org/10.18632/oncotarget.25408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995224/
https://www.ncbi.nlm.nih.gov/pubmed/29899833
http://dx.doi.org/10.18632/oncotarget.25408

Ejemplares similares